Tatyana Kanzaveli (@glfceo) 's Twitter Profile
Tatyana Kanzaveli

@glfceo

Investor, Entrepreneur,CEO Openhealth.cc,TEDxBayArea organizer, TEDx speaker; WomenInGenAI.ai founder; AI & GenAI evangelist

ID: 13493142

linkhttps://tatyana.expert calendar_today14-02-2008 22:45:18

116,116K Tweet

12,12K Followers

8,8K Following

Tatyana Kanzaveli (@glfceo) 's Twitter Profile Photo

Exciting news! 🚀 TrialsSphere, our GenAI-powered clinical trials platform, is receiving rave reviews for its powerful, intuitive interface. Enhancing the clinicaltrials.gov experience like never before—streamlining trial discovery and accelerating enrollment. A new era of

Richard Nieva (@richardjnieva) 's Twitter Profile Photo

Exclusive: Salesforce Ventures has added another $500 million to its Generative AI Fund, pushing its commitment to AI ventures to $1 billion over the last year and a half. forbes.com/sites/richardn…

Atul Butte (@atulbutte) 's Twitter Profile Photo

Way before CRISPR, we were excited about ribozymes, for which Thomas Cech won the The Nobel Prize in 1989. One of my ideas in 1994-5 was to design software that could customize target selection, given what was known about the cutting "rules" and the known genome. My C code helped me

Way before CRISPR, we were excited about ribozymes, for which Thomas Cech won the <a href="/NobelPrize/">The Nobel Prize</a> in 1989. One of my ideas in 1994-5 was to design software that could customize target selection, given what was known about the cutting "rules" and the known genome. My C code helped me
Tatyana Kanzaveli (@glfceo) 's Twitter Profile Photo

Fei-Fei Li has launched a new startup, World Labs, dedicated to creating AI models that can understand and generate 3D environments. Rather than concentrating on LLMs, World Labs will focus on developing LWMs (Large World Models). 🔥

Clara Shih (@clarashih) 's Twitter Profile Photo

Welcome to Dreamforce ☁️ Week! Very excited to announce Salesforce Ventures's new $500M AI Fund, bringing our total committed to $1B! Thus far we've invested in awesome AI startups like Hugging Face Anthropic Runway Typeface & more that all play a key role in our

Tatyana Kanzaveli (@glfceo) 's Twitter Profile Photo

🌟🌟🌟 Your org won’t see any real gains from #GenAI unless you’re ready to rethink how you work from the ground up. Deploying #AI without overhauling business processes is like putting a jet engine on a tricycle. #GenAI #BusinessTransformation #FutureOfWork #WomenInGenAI

Tatyana Kanzaveli (@glfceo) 's Twitter Profile Photo

GenAI has the potential to supercharge efficiency and innovation, but only if it's integrated into reimagined workflows. 👉 Without reengineering business processes, AI simply automates the same inefficiencies, creating minimal value. 🌟 For GenAI to deliver meaningful

Intuitive Machines (@int_machines) 's Twitter Profile Photo

NASA has awarded Intuitive Machines a Near Space Network Contract with a maximum potential value of $4.82 billion. As part of the contract, Intuitive Machines will deploy lunar relay satellites and provide communication & navigation services that play an essential role in NASA’s

Mario Nawfal (@marionawfal) 's Twitter Profile Photo

🚨NASA TRACKS STADIUM-SIZED ASTEROID FLYING 'RELATIVELY CLOSE' TO EARTH NASA is monitoring asteroid 2024 ON, a massive 1,150-foot by 590-foot object moving at 20,000 mph. It passed within 621,000 miles of Earth on Tuesday morning, close enough to be deemed "potentially

🚨NASA TRACKS STADIUM-SIZED ASTEROID FLYING 'RELATIVELY CLOSE' TO EARTH

NASA is monitoring asteroid 2024 ON, a massive 1,150-foot by 590-foot object moving at 20,000 mph.

It passed within 621,000 miles of Earth on Tuesday morning, close enough to be deemed "potentially
Tatyana Kanzaveli (@glfceo) 's Twitter Profile Photo

Day 1 at the DPharm 2024 conference was a wake-up call to anyone still thinking clinical trials are stuck in the past. It’s clear: disruption is the name of the game. GenAI AI, automation, and hybrid trials aren’t just buzzwords anymore—they’re the backbone of where drug

Day 1 at the DPharm 2024 conference was a wake-up call to anyone still thinking clinical trials are stuck in the past. 

It’s clear: disruption is the name of the game. GenAI AI, automation, and hybrid trials aren’t just buzzwords anymore—they’re the backbone of where drug
Tatyana Kanzaveli (@glfceo) 's Twitter Profile Photo

Today, we embarked on a journey to revolutionize clinical trials. 🚀 Met with pharma leaders at #DPharm2024 who share our vision for TrialsSphere—a groundbreaking way to accelerate protocol development. 🔥 The future of medicine is unfolding. 🌟 Stay tuned. #GenAI #dpharm

Today, we embarked on a journey to revolutionize clinical trials. 🚀

Met with pharma leaders at #DPharm2024 who share our vision for TrialsSphere—a groundbreaking way to accelerate protocol development. 🔥

The future of medicine is unfolding. 🌟

Stay tuned.

#GenAI #dpharm
Brian Roemmele (@brianroemmele) 's Twitter Profile Photo

“ALL 23andMe independent directors resign from board” Some saw this coming and there will be a bit more up ahead. 2025 will not compare to any other point in the past. cnbc.com/2024/09/17/23a…